Statera Biopharma, Inc.
DelistedCIK 1318641fmd_0VAH59JRM150KG4JC95J6DAANYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 02, 2009 to Sep 30, 2022, 51 periods
Latest annual · FY2021
Millions- Total revenues
- 1
- Gross profit
- 1
- Operating income
- (98)
- Net income
- (102)
- Free cash flow
- (28)
Latest quarter · Q3 FY2022
Millions- Total revenues
- 1
- Gross profit
- 1
- Operating income
- (2)
- Net income
- (3)
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- +9.3%
- Revenue, 5 yearsFY2016 to FY2021
- n/m
- Net income, 5 yearsFY2016 to FY2021
- n/m
Statera Biopharma, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.5 million | $0 | 10-K 2022-10-06 · proof | |
| Gross profit | $998,722 | $0 | 10-K 2022-10-06 · proof | |
| Operating income | -$98.3 million | -$10.5 million | 10-K 2022-10-06 · proof | |
| Net income | -$101.9 million | -$12.1 million | 10-K 2022-10-06 · proof | |
| Cash from operating activities | -$28.2 million | -$5.1 million | 10-K 2022-10-06 · proof | |
| Free cash flow | -$28.4 million | -$5.1 million | 10-K 2022-10-06 · proof | |
| Total assets | $21.2 million | $1 million | +1,944.4% | 10-K 2022-10-06 · proof |
| Total liabilities | $22.7 million | $4.7 million | +383.4% | 10-K 2022-10-06 · proof |
| Cash and cash equivalents | $1.8 million | $593,869 | +210.6% | 10-K 2022-10-06 · proof |
- What was Statera Biopharma, Inc.'s revenue in fiscal 2021?
- Statera Biopharma, Inc. reported revenue of $1.5 million for fiscal 2021 (the year ended Dec 31, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
- What was Statera Biopharma, Inc.'s gross profit in fiscal 2021?
- Statera Biopharma, Inc. reported gross profit of $998,722 for fiscal 2021 (the year ended Dec 31, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
- What was Statera Biopharma, Inc.'s operating income in fiscal 2021?
- Statera Biopharma, Inc. reported operating income of -$98.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$10.5 million the year before. Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
- What was Statera Biopharma, Inc.'s net income in fiscal 2021?
- Statera Biopharma, Inc. reported net income of -$101.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$12.1 million the year before. Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
- What was Statera Biopharma, Inc.'s cash from operating activities in fiscal 2021?
- Statera Biopharma, Inc. reported cash from operating activities of -$28.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$5.1 million the year before. Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
- What was Statera Biopharma, Inc.'s free cash flow in fiscal 2021?
- Statera Biopharma, Inc. reported free cash flow of -$28.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$5.1 million the year before. Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
- What are Statera Biopharma, Inc.'s total assets?
- As of Dec 31, 2021, Statera Biopharma, Inc. reported total assets of $21.2 million, against $1 million a year earlier (+1,944.4%). Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
- What are Statera Biopharma, Inc.'s total liabilities?
- As of Dec 31, 2021, Statera Biopharma, Inc. reported total liabilities of $22.7 million, against $4.7 million a year earlier (+383.4%). Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
- What are Statera Biopharma, Inc.'s cash and cash equivalents?
- As of Dec 31, 2021, Statera Biopharma, Inc. reported cash and cash equivalents of $1.8 million, against $593,869 a year earlier (+210.6%). Source: the 10-K filed with the SEC on Oct 6, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1318641&period_type=annual&limit=5"Information only, not investment advice.